Dermapharm Holding SE (ETR:DMP)

Dermapharm Holding SE Income Statement

Financials in millions EUR. Fiscal year is January - December.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Operating Revenue	1,177	1,195	1,150	1,040	959.6
Other Revenue	0.92	0.75	0.42	0.25	0.49
Revenue	1,178	1,195	1,151	1,041	960.09
Revenue Growth (YoY)	-1.43%	3.89%	10.59%	8.38%	18.78%
Cost of Revenue	412.65	445.6	446.6	391.85	349.87
Gross Profit	765.74	749.85	704.14	648.7	610.22
Selling, General & Admin	299.27	287.43	271.01	190.56	168.95
Other Operating Expenses	149.03	158.18	151.21	117.72	99.68
Operating Expenses	529.12	527.78	510.99	365.98	314.31
Operating Income	236.62	222.07	193.16	282.72	295.91
Interest Expense	-48.67	-58.41	-54.97	-12.34	-8.84
Interest & Investment Income	5.61	13.99	2.49	0.33	4.02
Earnings From Equity Investments	4.34	1.52	-7.16	-13.54	0.32
Currency Exchange Gain (Loss)	-4.81	1.4	-1.95	0.37	2.28
Other Non Operating Income (Expenses)	1.75	-0.96	-16.63	-1.12	-0.83
EBT Excluding Unusual Items	194.84	179.61	114.93	256.43	292.86
Merger & Restructuring Charges	-	-	-	-	-0.6
Impairment of Goodwill	-10.82	-2.12	-	-36.45	-5.43
Gain (Loss) on Sale of Investments	-	-0	-1.98	-	9.06
Gain (Loss) on Sale of Assets	0.28	0.63	2.96	3.13	1.38
Asset Writedown	-0.92	-6.21	-15.82	-7.03	-4.48
Other Unusual Items	-	-	5.78	-	-
Pretax Income	183.51	172.01	106	216.3	292.98
Income Tax Expense	52.16	60.27	45.46	83.68	84.07
Earnings From Continuing Operations	131.35	111.74	60.53	132.62	208.9
Minority Interest in Earnings	1.06	2.05	1.83	1.62	0.68
Net Income	132.41	113.79	62.37	134.24	209.58
Net Income to Common	132.41	113.79	62.37	134.24	209.58
Net Income Growth	16.37%	82.45%	-53.54%	-35.95%	144.19%
Shares Outstanding (Basic)	54	54	54	54	54
Shares Outstanding (Diluted)	54	54	54	54	54
EPS (Basic)	2.46	2.11	1.16	2.49	3.89
EPS (Diluted)	2.46	2.11	1.16	2.49	3.89
EPS Growth	16.37%	82.45%	-53.54%	-35.91%	144.65%
Free Cash Flow	187.03	163.14	177.88	249.52	189.17
Free Cash Flow Per Share	3.47	3.03	3.30	4.63	3.51
Dividend Per Share	0.880	0.900	0.880	1.050	2.170
Dividend Growth	-2.22%	2.27%	-16.19%	-51.61%	146.59%
Gross Margin	64.98%	62.72%	61.19%	62.34%	63.56%
Operating Margin	20.08%	18.58%	16.79%	27.17%	30.82%
Profit Margin	11.24%	9.52%	5.42%	12.90%	21.83%
Free Cash Flow Margin	15.87%	13.65%	15.46%	23.98%	19.70%
EBITDA	264.74	250.77	220.31	302.36	312.36
EBITDA Margin	22.47%	20.98%	19.14%	29.06%	32.53%
D&A For EBITDA	28.12	28.7	27.15	19.64	16.45
EBIT	236.62	222.07	193.16	282.72	295.91
EBIT Margin	20.08%	18.58%	16.79%	27.17%	30.82%
Effective Tax Rate	28.42%	35.04%	42.89%	38.69%	28.70%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.